SEARCH

SEARCH BY CITATION

References

  • Asselin, B.L., Ryan, D., Frantz, C.N., Bernal, S.D., Leavitt, P., Sallan, S.E. & Cohen, H.J. (1989) In vitro and in vivo killing of acute lymphoblastic leukemia cells by l-asparaginase. Cancer Research, 49, 43634368.
  • Den Boer, M.L., Pieters, R., Kazemier, K.M., Veerman, A.J., Harms, D.O. & Janka-Schaub, G. (2002) Stratification by prednisolone-vincristine-asparginase (PVA) resistance profiles in children with acute lymphoblastic leukemia (ALL) at inital diagnosis. Blood, 100, a2982.
  • Forestier, E., Johansson, B., Gustafsson, G., Borgstrom, G., Kerndrup, G., Johannsson, J. & Heim, S. (2000) Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group. British Journal of Haematology, 110, 147153.
  • Fridborg, H., Jonsson, E., Nygren, P. & Larsson, R. (1999) Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic. European Journal of Cancer, 35, 424432.
  • Gustafsson, G., Kreuger, A., Clausen, N., Garwicz, S., Kristinsson, J., Lie, S.O., Moe, P.J., Perkkio, M., Yssing, M. & Saarinen-Pihkala, U.M. (1998) Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatrics, 87, 11511161.
  • Gustafsson, G., Schmiegelow, K., Forestier, E., Clausen, N., Glomstein, A., Jonmundsson, G., Mellander, L., Makipernaa, A., Nygaard, R. & Saarinen-Pihkala, U.M. (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia, 14, 22672275.
  • Hamburger, A.W. & Salmon, S.E. (1977) Primary bioassay of human tumor stem cells. Science, 197, 461463.
  • Hirt, A., Leibundgut, K., Luthy, A.R., Von Der Weid, N. & Wagner, H.P. (1997) Cell birth and death in childhood acute lymphoblastic leukaemia: how fast does the neoplastic cell clone expand? British Journal of Haematology, 98, 9991001.
  • Von Hoff, D.D. (1988) Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development. Cancer Metastasis Review, 7, 357371.
  • Hongo, T., Fujii, Y. & Igarashi, Y. (1990) An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer, 65, 12631272.
  • Hongo, T., Yajima, S., Sakurai, M., Horikoshi, Y. & Hanada, R. (1997) In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood, 89, 29592965.
  • Hongo, T., Yamada, S., Yajima, S., Watanabe, C., Fujii, Y., Kawasaki, H., Yazaki, M., Hanada, R. & Horikoshi, Y. (1999) Biological characteristics and prognostic value of vitro three-drug resistance to prednisolone, l-asparaginase, and vincristine in childhood acute lymphoblastic leukemia. International Journal of Hematology, 70, 268277.
  • Kaspers, G.J., Pieters, R., Van Zantwijk, C.H., De Laat, P.A., De Waal, F.C., Van Wering, E.R. & Veerman, A.J. (1991) In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. British Journal of Cancer, 64, 469474.
  • Kaspers, G.J., Veerman, A.J., Pieters, R., Van Zantwijk, C.H., Smets, L.A., Van Wering, E.R. & Van Der Does-Van Den Berg, A. (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood, 90, 27232729.
  • Kern, D.H. & Weisenthal, L.M. (1990) Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. Journal of the National Cancer Institute, 82, 582588.
  • Larsson, R. (1998) Prediction of cytotoxic drug resistance in acute leukemia. In: Drug Resistance in Oncology (ed. by S.D.Bernal), pp. 249278. Marcel Dekker, New York.
  • Larsson, R. & Nygren, P. (1993) Laboratory prediction of clinical chemotherapeutic drug resistance: a working model exemplified by acute leukaemia. European Journal of Cancer, 29A, 12081212.
  • Larsson, R., Kristensen, J., Sandberg, C. & Nygren, P. (1992) Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA). International Journal of Cancer, 50, 177185.
  • Nygren, P., Kristensen, J., Jonsson, B., Sundstrom, C., Lonnerholm, G., Kreuger, A. & Larsson, R. (1992) Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia. Leukemia, 6, 11211128.
  • Nygren, P., Fridborg, H., Csoka, K., Sundstrom, C., De La Torre, M., Kristensen, J., Bergh, J., Hagberg, H., Glimelius, B., Rastad, J., Larsson, R. & Tholander, B. (1994) Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients. International Journal of Cancer, 56, 715720.
  • Pieters, R., Huismans, D.R., Leyva, A. & Veerman, A.J. (1988) Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Letters, 41, 323332.
  • Pieters, R., Huismans, D.R., Leyva, A. & Veerman, A.J. (1989) Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. British Journal of Cancer, 59, 217220.
  • Pieters, R., Kaspers, G.J., Klumper, E. & Veerman, A.J. (1994) Clinical relevance of vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art. Medical Pediatric Oncology, 22, 299308.
  • Preisler, H.D., Azarnia, N. & Marinello, M. (1984) Relationship of the growth of leukemic cells in vitro to the outcome of therapy for acute nonlymphocytic leukemia. Cancer Research, 44, 17121717.
  • Pui, C.H. & Evans, W.E. (2001) Risk assessment in acute lymphoblastic leukemia: beyond leukemia cell characteristics. Journal of Pediatric Hematology/Oncology, 23, 405408.
  • Schmiegelow, K., Nyvold, C., Seyfarth, J., Pieters, R., Rottier, M.M., Knabe, N., Ryder, L.P., Madsen, H.O., Svejgaard, A. & Kaspers, G.J. (2001) Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. Leukemia, 15, 10661071.
  • Schrappe, M., Camitta, B., Pui, C.H., Eden, T., Gaynon, P., Gustafsson, G., Janka-Schaub, G.E., Kamps, W., Masera, G., Sallan, S., Tsuchida, M. & Vilmer, E. (2000) Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia, 14, 21932194.
  • Tannock, I. (1987) The basic science of oncology. Pergamon Press, New York.
  • Wagner, A., Hempel, G., Gumbinger, H.G., Jurgens, H. & Boos, J. (1999) Pharmacokinetics of anticancer drugs in vitro. Advances in Experimental Medical Biology, 457, 397407.
  • Weisenthal, L.M. & Kern, D.H. (1991) Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assays. Oncology (Huntington's), 5, 93103 .
  • Weisenthal, L.M. & Lippman, M.E. (1985) Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treatment Rep, 69, 615632 .
  • Weisenthal, L.M., Dill, P.L., Kurnick, N.B. & Lippman, M.E. (1983) Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Research, 43, 258264.
  • Wilbur, D.W., Camacho, E.S., Hilliard, D.A., Dill, P.L. & Weisenthal, L.M. (1992) Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill. British Journal of Cancer, 65, 2732.